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Nanosized liposomes are among technological delivery methods for chemotherapeutic drugs in the 
treatment of cancer. This technique can potentially overcome many common pharmacologic problems, 
such as those involving solubility, pharmacokinetics, in vivo stability and toxicity [1,2]. Liposomes are 
closed spherical vesicles consisting of a lipid bilayer that encapsulates an aqueous phase in which 
hydrophilic drugs can be stored, while water insoluble compounds can be incorporated in the 
hydrophobic region of the lipid bilayer [3]. 
In this work, two new potential antitumoral fluorescent tetracyclic thieno[3,2-b]pyridine derivatives 1 and 
2 (structures shown below), previously synthesized by some of us [4], were encapsulated in nanosized 
liposomes of DPPC (dipalmitoyl phosphatidylcholine), egg lecithin (phosphatidylcholine from egg yolk) 
and DODAB (dioctadecyldimethylammonium bromide). The phospholipids DPPC and egg lecithin (Egg-
PC) are neutral components of biological membranes, while cationic liposomes based on the synthetic 
lipid DODAB have been used as vehicles for DNA transfection and drug delivery [5]. 
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The investigation based on DNA interactions has a key importance in order to understand the 
mechanisms of action of antitumor and antiviral drugs and to design new DNA-targeted drugs [6]. Both 
compounds 1 and 2 were tested for their interaction with salmon sperm DNA using spectroscopic 
methods. These studies allowed to determine the binding constants and binding site sizes (in base 
pairs), through the McGhee and von Hippel modification of Scatchard plot [7] (Equation 1 and Table 1), 
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where Ki is the intrinsic binding constant, n is the binding site size, r is the ratio cb/[DNA], cb and cf are 
the concentrations of bound and free compound, respectively. Fluorescence quenching experiments 
using external quenchers are also very useful to establish the DNA-binding modes, since intercalated 
chromophores are less accessible to anionic quenchers due to electrostatic repulsion with negatively 
charged DNA [8]. Quenching measurements using iodide ion showed that both compounds exhibit 
some intercalation in DNA, compound 2 being the more intercalative one, with a lower fraction of 
molecules accessible to quencher (Table 1).  
 
Table 1. Binding constants to DNA (Ki), binding site sizes (n) and fraction of compound molecules 
accessible to external quenchers (fa) 
 Ki (M-1) n (base pairs) fa 
Compound 1 (8.7 ± 0.9)×103 11 ± 3 0.89 
Compound 2 (5.9 ± 0.6)×103 7 ± 2 0.65 
 
  
Considering the antitumoral potential of these compounds, the encapsulation in nanoliposomes is 
important for future drug delivery assays. Monodisperse and nanosized liposomes were prepared by 
injection of an ethanolic solution of the lipid in an aqueous media under vigorous stirring, above the lipid 
melting transition temperature (Tm~ 41 ºC for DPPC and 45 ºC for DODAB). The hydrodynamic 
diameters of 87 ± 11 nm for DPPC, 51 ± 2 nm for Egg-PC and 268 ± 37 nm for DODAB were obtained 
by dynamic light scattering. 
Fluorescence experiments of both compounds encapsulated in nanosized liposomes were carried out 
(Figure 1), in both gel (below Tm) and liquid-crystalline (above Tm) phases. Fluorescence anisotropy 
measurements allowed to conclude that compound 1 prefers an hydrated environment in the 
nanoliposomes, while compound 2 can be transported in the hydrophobic region of the lipid bilayer, 
especially in Egg-PC nanoliposomes. 
 
Figure 1. Normalized fluorescence emission spectra of compounds 1 and 2 incorporated in 
nanoliposomes of DPPC, Egg-PC and DODAB. 
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